Progress in neonatal methemoglobinemia / 国际儿科学杂志
International Journal of Pediatrics
; (6): 744-748, 2022.
Article
em Zh
| WPRIM
| ID: wpr-954113
Biblioteca responsável:
WPRO
ABSTRACT
Neonatal methemoglobinemia is a rare disorder characterized by cyanosis and hypoxemia, which could be caused congenitally by cytochrome b5 reductase enzyme deficiency or hemoglobin M disease, and could be acquired by the exposure to lidocaine, nitrites and other drugs.Blood gas analysis is a simple and accessible way to detect methomoglobin.Methemoglobinemia is related to numerous diseases in neonates, including diarrhea, acidosis, late-onset sepsis.Methylene blue is an effective drug for decreasing MetHb levels.Other therapeutic options, such as vitamin C, N-acetylcysteine and vitamin B2, could also be useful.This article reviews the progress of neonatal methemoglobinemia.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
International Journal of Pediatrics
Ano de publicação:
2022
Tipo de documento:
Article